Optimizing Patient Adherence to Pharmaceutical Care Plans 1.

Slides:



Advertisements
Similar presentations
Depression in adults with a chronic physical health problem
Advertisements

Communication to Promote Therapeutic Adherence Ellen R. Cohn PhD University of Pittsburgh
Keeping Pre-ERSD Patients Pre-ERSD: Using the Health Belief Model
Introduction Medication non adherence ( noncompliance) remains a major problem. You have to assess and treat adherence related problems that can adversely.
Andrew M. Peterson, PharmD, PhD Dean, Mayes College of Healthcare Business and Policy University of the Sciences Prescribing Practices.
Reducing Need and Demand for Health Care Gero 302 Jan 2011.
Disease State Management The Pharmacist’s Role
Copyright © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 35Seriously and Persistently Mentally Ill, Homeless, or Incarcerated Clients.
Self-Regulation in Chronic Disease Noreen M. Clark, Ph.D. March 23, 2002.
The Value of Medication Therapy Management Services
Innovative Pharmacy Services Jann B. Skelton, RPh, MBA Vice President of Operations MEDICA.
How to improve the patient ADHERENCE to clinical trials ?
The challenge of medicines non-adherence. 2 How is adherence defined? WHO definition: ‘the extent to which a person’s behaviour – taking medication, following.
Lecture 3: Health Psychology and Physical Illnesses I (Part 2)
FACTORS HINDERING ATTITUDE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN THE NIGER DELTA, NIGERIA by AGOFURE OTOVWE and OYEWOLE OYEDIRAN.
Improving Medication Management Support for Older Adults: A Pilot Study Susan L. Lakey, PharmD Acting Assistant Professor University of Washington Department.
Child Health Disparities Denice Cora-Bramble, MD, MBA Professor of Pediatrics, George Washington University Executive Director Goldberg Center for Community.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Promoting Adherence in Children. What are the challenges faced by children that interfere with ART adherence? B ased on your knowledge and experience,
Concordance Monica Arora © Swindon/Bath GPR Day Release Course 2006.
Clinical Pharmacy II Lobna Al Juffali,MSc Fall-2009.
Measuring Compliance n Self report Problem is patients overestimate their compliance level.
OPTIMISING MEDICINES USE GRAHAM DAVIES Professor of Clinical Pharmacy & Therapeutics Institute of Pharmaceutical Science King’s College London.
Ambulatory care Prepared by: Nehad Ahmed. Ambulatory care is Primary care-based services and services provided from office-based specialists and hospital.
Patient Compliance With Medical Advice. Patient compliance (patient adherence) :  The extent to which the patient adheres to medical advice Patient compliance.
Readmission and Chronic illness that could benefit from end of life discussions.
Improving Medication Compliance Among College Students Presented to the American College Health Association May 31, 2012 by Benjamin F. Banahan III, Ph.D.,
Schizophrenia Case Study
Behavioral Health Issues and Pediatric Hospitalizations Stephen R. Gillaspy, PhD 11/05/09 Reaching Out To Oklahoma III Annual Pediatric Interdisciplinary.
Chapter 21: Adherence to Medical Regimens Alan M. Delamater Ashley Marchante Amber Daigre.
Establishing Preventive Cardiology Programs Nathan Wong Nathan Wong.
Dr Pamela Smith – Fall  Definition = development of resources necessary to provide mental health care within a given setting or community  Function.
HRET/K-HEN Readmissions Race Office Hour Building a Multidisciplinary Care Transitions Team January 25, 2013.
Pharmacoeconomics & Drug Compliance Dr Arif Hashmi.
Following Your Treatment Plan. Taking your medication is an important part of your treatment. 2.
Pattern of Diabetes Emergencies among adult Yemeni Diabetic Patients Dr. Zayed Atef Faculty of Medicine Sana’a University.
Psychological Impact of Asthma in Children Kristin A. Kullgren, Ph.D.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
1 Assessing and Improving ARV Adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
The Value of Medication Therapy Management Services.
Medication Adherence The following module is designed as a basic overview of medication adherence for providers of healthcare, particularly those in a.
1 Asthma October 30, Weiss, Gergen, & Hodgson (1992)2 Pediatric Statistics Prevalence increasing School absences Estimated as more than 10 million.
Illness Behavior in the Elderly C. Eberle, M.D. University of Nebraska Medical Center.
PHCL 436 Lecture two. Objectives  The role of cognition in influencing adjustment to chronic conditions  What is medication adherence, prevalence, reasons,
1 Care for Injection Drug Users (IDUs) with HIV HAIVN Havard Medical School AIDS Initiative in Vietnam.
Copyright © 2015 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
Care Management 101 Governor's Office of Health Care Reform October 28, 2010 Cathy Gorski, RN, BS, CCM.
Polypharmacy May 2008 CRIT Heidi Auerbach, MD Copyright Boston University Medical Center.
Care Experience Breakout Sessions Trudi Marshall
Pharmacists Working In Primary Healthcare Centers: Are They Ready To Expand Their Role? Sinaa Alageel, MSc, PhD; Norah Abanmy MSc Department of Clinical.
© 2015 Omnicell, Inc. Content is confidential and proprietary 1 Multimed Adherence Packaging Your Pharmacy Logo Goes Here.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
Better Patient Adherence: Why patients don’t adhere and what we can do about it (maybe) Frank Doyle, PhD RCSI Royal College of Surgeons in Ireland Coláiste.
100 years of living science Chronic disease management in primary care: lessons to be learnt Dr Shamini Gnani November 2007, Mauritius.
Carol A. Miller, MD Professor, Pediatrics UCSF Benioff Children’s Hospital And the Asthma Task Force Team.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Chapter 7: Epidemiology of Chronic Diseases. “The Change You Like to See….” (1 of 3) Chronic diseases result from prolongation of acute illness. – With.
Pharmacy Health Information Technology Collaborative Presenter: Shelly Spiro RPh, FASCP Pharmacy HIT Collaborative, Executive Director.
Aging, Health and Mental Health Prepared for distribution by the CSWE Gero-Ed Center.
Jacqueline Dunbar-Jacob, PhD, RN, FAAN Dean, School of Nursing University of Pittsburgh School of Nursing Center for Research in Chronic Disorders.
PHARMACEUTICAL GUIDELINES: BASIC PRINCIPLES AND STATUTES.
The challenge of medicines
Prescribing.
Clinical Pharmacy II.
Chapter Eleven: Management of Chronic Illness
PATIENT MEDICATION ADHERENCE
Chelsea Stellmach, MS with Alison DiValerio, MS, RN
Communication Skills Lecture 1-2
Rhematoid Rthritis Respiratory disorders
Presentation transcript:

Optimizing Patient Adherence to Pharmaceutical Care Plans 1

Objectives Background Burden of non-Adherence Definitions Factors affecting patient adherence Interventions to detect and assess adherence/non-adherence Consideration for special populations Strategies to optimize adherence to pharmaceutical care plans (prevention and resolving nonadherence) 2

Lecture Resources Medication Adherence : Its Importance in Cardiovascular Outcomes. Circulation. 2009;119: Optimizing Adherence to Pharmaceutical Care Plans. J Am Pharm Assoc. 2000;40(4). Accessed from: Enhancing Prescription Medicine Adherence: A National Action Plan (2007). Accessed from: n_medicine_adherence.pdf n_medicine_adherence.pdf 3

Background Nonadherence has serious negative impact on patient’s and health outcomes Considered as an "invisible epidemic” “America’s Other Drug Problem” It affect all age and ethnic groups 4

Background About 69% of non-adherence to drug therapy is behavioral in nature resulting from forgetfulness or procrastination Share many characteristics of medical disorders 5

Non-adherence rates are high among patients with chronic diseases 6

“Poor adherence to treatment of chronic diseases is a worldwide problem of striking magnitude. Adherence to long-term therapy for chronic illnesses in developed countries averages 50%. (WHO 2003) 7

“A worldwide problem of striking magnitude” In USA: Three out of every four American consumers report not always taking their prescription medicine as directed*. Forgetfulness: 49% Didn’t refill: 31% Ran out of medicine: 29% Took less dose than recommended: 24% About 33% to 69% of medication related hospital admissions are due to poor adherence 8 * Survey conducted by National Community Pharmacists Association-2006

“A worldwide problem of striking magnitude” In UK 20-30% don’t adhere to regimens that are curative or relieve symptoms 30-40% fail to follow regimens designed to prevent health problems 33-50% of newly prescribed medicines are subject to non- adherence 9 Survey by The New Medicines Service (NMS), a service commissioned by the Department of Health-UK

Nonadherence in Saudi Population Data from Saudi Arabia Hypertensive patient has a compliance rate of 34.2% Factors: organizational variables (time spent with the doctor, continuity of care by the doctor, communication style of the doctor and interpersonal style of the doctor) 10 Khalil et al. Journal of Hypertension, 1997, 15: Albaz RS. Journal of Social Sciences, 1997, 25:5-8.

Nonadherence in Saudi Population Medication adherence among patients in a chronic disease clinic Cross sectional study, n= 347 Age and asthma were significantly associated with low motivation Single status was the only independent predictor of low adherence intention 11 Tourkmani, Saudi Med J Dec;33(12):

“A worldwide problem of striking magnitude” 1.Adverse Heath outcomes:  Decrease productivity  Increase disease morbidity  Increase physician office visits  Hospital re/or-admissions  Death 2.Pharmacies also lose revenue because patients often fail to refill prescription medications, especially for chronic diseases 12

“A worldwide problem of striking magnitude” 3.Economic Burden: Data from USA: Annual deaths caused by non-adherence is estimated to be 125,000 Cost: nearly $300 billion annually in direct and indirect costs – Mostly due to readmissions » 70% of which are attributable to medication non-compliance among the elderly 13

What is the definition of nonadherence? “Drugs don't work in patients who don't take them” 14 - C. Everett Koop, M.D.

The extent to which a person’s behavior – taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider. The definition best describes Compliance Adherence Persistence 15

Definitions Compliance: the extent to which the patient’s behavior matches the prescriber’s recommendations’ 1 Adherence: ‘the extent to which the patient’s behavior matches agreed upon recommendations from the prescriber’ Medication persistence: “the length of time from initiation to discontinuation of therapy” 16 Haynes R, et al Barofsky I. 1978, Cramer, Value Health 2008;11:44–7.

More than just medications…. Nonadherence encompass any of the following: Medications Recommended lifestyle changes: exercise or smoking cessation Prescribed non-pharmacologic interventions: physical therapy or dietary plans 17

Medication Nonadherence Can take many forms: Not having a prescription filled Taking an incorrect dose Taking medications at incorrect times Forgetting to take doses Stopping therapy before the recommended time Drug Holiday 18

What does the patient Really Say... “If I don’t put my pills on my plate 3 times a day, my wife will put them for me, there is no question about that!” “I believe the doctor will know. He is trained regularly, he knows the newest things. What do we know about it? I suppose that it is necessary to take the medication.” 19

What does the patient Really Say.. “That is why I always ask for samples.. I take a lot of medicines and it is very expensive.” “I never forget my medication, except for the one pill that I have to take twice.” “I couldn’t make neither head or tail because in hospital they have another name for the same tablet.” “I didn’t take my diuretics (metoprolol) because of my visit to HF clinic.” 20

What does the patient Really Say.. “It is just a routine… I put the tablets on the breakfast table and hope I take them.” “I suppose it is a built-in fear; if you don’t comply you will end up back in the hospital again-and you don’t want that, do you? “When you so far gone as I am now, you will take them, you have no choice.” 21

Major Risk Factors for Non-Adherence 1.Asymptomatic conditions 2.Chronic conditions 3.Cognitive impairments, especially forgetfulness 4.Complex regimens 5.Multiple daily doses and polypharmacy 6.Patient fears and concerns related to medication effects 7.Poor communication 22

Causes for Nonadherence Reasons for patient non-adherence are complex and multidimensional Many internal and external factors The WHO define 5 dimensions for nonadherence: Social/economic factors Provider-patient/health care system factors Condition-related factors Therapy-related factors Patient-related factors 23

Factors affecting Patient Adherence 24

I. Social and economic factors Poor socioeconomic status and poverty Illiteracy, low level of education Unemployment Lack of effective social support networks Unstable living conditions (Wars) Long distance from treatment center High cost of transport; high cost of medication 25

I. Social and economic factors Changing environmental situations Culture and lay beliefs about illness and treatment Family dysfunction Race: cultural beliefs, social inequalities Age: Children, Adolescent, Elderly 26

II. Health care team and system-related factors Poorly developed health services Poor medication distribution systems Lack of knowledge and training for health care providers on managing chronic diseases, overworked health care providers Lack of incentives and feedback on performance Short consultations times 27

II. Health care team and system-related factors Weak capacity of the system to educate patients and provide follow-up Inability to establish community support and self-management capacity Lack of knowledge on adherence and of effective interventions for improving it 28

III. Condition-related factors Severity of symptoms Level of disability (physical, psychological, social and vocational) Rate of progression and severity of the disease The availability of effective treatments Comorbidities: depression Substance of abuse 29

IV. Therapy-related factors Complexity of the medical regimen Duration of treatment Previous treatment failures Frequent changes in treatment The immediacy of beneficial effects Side-effects and the availability of medical support to deal with them 30

V. Patient-related factors Knowledge and beliefs about illness, motivation to manage it Expectations regarding the outcome of treatment and the consequences of poor adherence Inadequate knowledge and skill in managing the disease symptoms and treatment Misunderstanding of treatment instructions 31

V. Patient-related factors Negative beliefs regarding the efficacy of the treatment Lack of perception of the health risk related to the disease Lack of self-perceived need for treatment Lack of perceived effect of treatment 32

V. Patient-related factors Anxieties about possible adverse effects Low motivation Low attendance at follow up, or at counseling, motivational, behavioral, or psychotherapy classes Hopelessness and negative feelings Frustration with health care providers 33

V. Patient-related factors Forgetfulness Psychosocial stress Misunderstanding and non-acceptance of the disease Lack of acceptance of monitoring Disbelief in the diagnosis Low treatment expectations 34

Patient-related factors Fear of dependence Anxiety over the complexity of the drug regimen Perceived effect of treatment Feeling stigmatized by the disease 35

Next Lecture Assessing Adherence Resolving adherence problem Preventing adherence 36